Development of allosteric and selective CDK2 inhibitors for contraception with negative cooperativity to cyclin binding.Published in:Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-38732-xBy:Faber, Erik B.;Sun, Luxin;Tang, Jian;Roberts, Emily;Ganeshkumar, Sornakala;Wang, Nan;Rasmussen, Damien;Majumdar, Abir;Hirsch, Laura E.;John, Kristen;Yang, An;Khalid, Hira;Hawkinson, Jon E.;Levinson, Nicholas M.;Chennathukuzhi, Vargheese;Harki, Daniel A.;Schönbrunn, Ernst;Georg, Gunda I.Publication type:Article